世界の抗生物質有効成分市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Antibiotics Active Pharmaceutical Ingredient Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3821
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、106ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、抗生物質有効成分の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質）、用途別市場規模（製薬会社、医薬品製造受託機関（CMO）、医薬品製造受託機関（CDMO））、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・抗生物質有効成分の市場動向
・企業の競争状況、市場シェア
・抗生物質有効成分の種類別市場規模と予測2016-2027（ペニシリン系抗生物質、セファロスポリン系抗生物質、カルバペネム系抗生物質）
・抗生物質有効成分の用途別市場規模と予測2016-2027（製薬会社、医薬品製造受託機関（CMO）、医薬品製造受託機関（CDMO））
・抗生物質有効成分の北米市場規模2016-2027（アメリカ、カナダ）
・抗生物質有効成分の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・抗生物質有効成分のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・抗生物質有効成分の中南米市場規模2016-2027（メキシコ、ブラジル）
・抗生物質有効成分の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Sandoz International、Centrient Pharmaceuticals、CordenPharma International、ACS DOBFAR、Nanjing Dorra Pharmaceutical Technology、DAEWOONG PHARMACEUTICAL、Parabolic Drugs、Penam Laboratories、ASIATIC DRUGS & PHARMACEUTICALS、Fresenius Kabi、The United Laboratories International Holdings、Aurobindo Pharma Limited、Unimark Remedies、Savior Lifetec）
・結論

Market Analysis and Insights: Global Antibiotics Active Pharmaceutical Ingredient Market
The global Antibiotics Active Pharmaceutical Ingredient market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Antibiotics Active Pharmaceutical Ingredient market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Antibiotics Active Pharmaceutical Ingredient market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Antibiotics Active Pharmaceutical Ingredient market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Antibiotics Active Pharmaceutical Ingredient market.

Global Antibiotics Active Pharmaceutical Ingredient Scope and Market Size
Antibiotics Active Pharmaceutical Ingredient market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Antibiotics Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Penicillin Antibiotics
Cephalosporins
Carbapenem Antibiotics

Segment by Application
Pharmaceutical Companies
Contract Manufacturing Organizations (CMOs)
Contract Development & Manufacturing Organizations (CDMOs)

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sandoz International
Centrient Pharmaceuticals
CordenPharma International
ACS DOBFAR
Nanjing Dorra Pharmaceutical Technology
DAEWOONG PHARMACEUTICAL
Parabolic Drugs
Penam Laboratories
ASIATIC DRUGS & PHARMACEUTICALS
Fresenius Kabi
The United Laboratories International Holdings
Aurobindo Pharma Limited
Unimark Remedies
Savior Lifetec

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibiotics Active Pharmaceutical Ingredient Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Penicillin Antibiotics
1.2.3 Cephalosporins
1.2.4 Carbapenem Antibiotics
1.3 Market by Application
1.3.1 Global Antibiotics Active Pharmaceutical Ingredient Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical Companies
1.3.3 Contract Manufacturing Organizations (CMOs)
1.3.4 Contract Development & Manufacturing Organizations (CDMOs)
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antibiotics Active Pharmaceutical Ingredient Market Perspective (2016-2027)
2.2 Antibiotics Active Pharmaceutical Ingredient Growth Trends by Regions
2.2.1 Antibiotics Active Pharmaceutical Ingredient Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Antibiotics Active Pharmaceutical Ingredient Historic Market Share by Regions (2016-2021)
2.2.3 Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Regions (2022-2027)
2.3 Antibiotics Active Pharmaceutical Ingredient Industry Dynamic
2.3.1 Antibiotics Active Pharmaceutical Ingredient Market Trends
2.3.2 Antibiotics Active Pharmaceutical Ingredient Market Drivers
2.3.3 Antibiotics Active Pharmaceutical Ingredient Market Challenges
2.3.4 Antibiotics Active Pharmaceutical Ingredient Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antibiotics Active Pharmaceutical Ingredient Players by Revenue
3.1.1 Global Top Antibiotics Active Pharmaceutical Ingredient Players by Revenue (2016-2021)
3.1.2 Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Players (2016-2021)
3.2 Global Antibiotics Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antibiotics Active Pharmaceutical Ingredient Revenue
3.4 Global Antibiotics Active Pharmaceutical Ingredient Market Concentration Ratio
3.4.1 Global Antibiotics Active Pharmaceutical Ingredient Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibiotics Active Pharmaceutical Ingredient Revenue in 2020
3.5 Antibiotics Active Pharmaceutical Ingredient Key Players Head office and Area Served
3.6 Key Players Antibiotics Active Pharmaceutical Ingredient Product Solution and Service
3.7 Date of Enter into Antibiotics Active Pharmaceutical Ingredient Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antibiotics Active Pharmaceutical Ingredient Breakdown Data by Type
4.1 Global Antibiotics Active Pharmaceutical Ingredient Historic Market Size by Type (2016-2021)
4.2 Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Type (2022-2027)

5 Antibiotics Active Pharmaceutical Ingredient Breakdown Data by Application
5.1 Global Antibiotics Active Pharmaceutical Ingredient Historic Market Size by Application (2016-2021)
5.2 Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
6.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type
6.2.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
6.2.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
6.2.3 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
6.3 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application
6.3.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
6.3.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
6.3.3 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
6.4 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country
6.4.1 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021)
6.4.2 North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
7.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type
7.2.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
7.2.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
7.2.3 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
7.3 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application
7.3.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
7.3.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
7.3.3 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
7.4 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country
7.4.1 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021)
7.4.2 Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
8.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type
8.2.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
8.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application
8.3.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
8.4 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region
8.4.1 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
9.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type
9.2.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
9.2.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
9.2.3 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
9.3 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application
9.3.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
9.3.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
9.3.3 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
9.4 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country
9.4.1 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021)
9.4.2 Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size (2016-2027)
10.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type
10.2.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2027)
10.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application
10.3.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2027)
10.4 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country
10.4.1 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Sandoz International
11.1.1 Sandoz International Company Details
11.1.2 Sandoz International Business Overview
11.1.3 Sandoz International Antibiotics Active Pharmaceutical Ingredient Introduction
11.1.4 Sandoz International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.1.5 Sandoz International Recent Development
11.2 Centrient Pharmaceuticals
11.2.1 Centrient Pharmaceuticals Company Details
11.2.2 Centrient Pharmaceuticals Business Overview
11.2.3 Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Introduction
11.2.4 Centrient Pharmaceuticals Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.2.5 Centrient Pharmaceuticals Recent Development
11.3 CordenPharma International
11.3.1 CordenPharma International Company Details
11.3.2 CordenPharma International Business Overview
11.3.3 CordenPharma International Antibiotics Active Pharmaceutical Ingredient Introduction
11.3.4 CordenPharma International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.3.5 CordenPharma International Recent Development
11.4 ACS DOBFAR
11.4.1 ACS DOBFAR Company Details
11.4.2 ACS DOBFAR Business Overview
11.4.3 ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Introduction
11.4.4 ACS DOBFAR Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.4.5 ACS DOBFAR Recent Development
11.5 Nanjing Dorra Pharmaceutical Technology
11.5.1 Nanjing Dorra Pharmaceutical Technology Company Details
11.5.2 Nanjing Dorra Pharmaceutical Technology Business Overview
11.5.3 Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Introduction
11.5.4 Nanjing Dorra Pharmaceutical Technology Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.5.5 Nanjing Dorra Pharmaceutical Technology Recent Development
11.6 DAEWOONG PHARMACEUTICAL
11.6.1 DAEWOONG PHARMACEUTICAL Company Details
11.6.2 DAEWOONG PHARMACEUTICAL Business Overview
11.6.3 DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Introduction
11.6.4 DAEWOONG PHARMACEUTICAL Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.6.5 DAEWOONG PHARMACEUTICAL Recent Development
11.7 Parabolic Drugs
11.7.1 Parabolic Drugs Company Details
11.7.2 Parabolic Drugs Business Overview
11.7.3 Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Introduction
11.7.4 Parabolic Drugs Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.7.5 Parabolic Drugs Recent Development
11.8 Penam Laboratories
11.8.1 Penam Laboratories Company Details
11.8.2 Penam Laboratories Business Overview
11.8.3 Penam Laboratories Antibiotics Active Pharmaceutical Ingredient Introduction
11.8.4 Penam Laboratories Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.8.5 Penam Laboratories Recent Development
11.9 ASIATIC DRUGS & PHARMACEUTICALS
11.9.1 ASIATIC DRUGS & PHARMACEUTICALS Company Details
11.9.2 ASIATIC DRUGS & PHARMACEUTICALS Business Overview
11.9.3 ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Introduction
11.9.4 ASIATIC DRUGS & PHARMACEUTICALS Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.9.5 ASIATIC DRUGS & PHARMACEUTICALS Recent Development
11.10 Fresenius Kabi
11.10.1 Fresenius Kabi Company Details
11.10.2 Fresenius Kabi Business Overview
11.10.3 Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Introduction
11.10.4 Fresenius Kabi Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.10.5 Fresenius Kabi Recent Development
11.11 The United Laboratories International Holdings
11.11.1 The United Laboratories International Holdings Company Details
11.11.2 The United Laboratories International Holdings Business Overview
11.11.3 The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Introduction
11.11.4 The United Laboratories International Holdings Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.11.5 The United Laboratories International Holdings Recent Development
11.12 Aurobindo Pharma Limited
11.12.1 Aurobindo Pharma Limited Company Details
11.12.2 Aurobindo Pharma Limited Business Overview
11.12.3 Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Introduction
11.12.4 Aurobindo Pharma Limited Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.12.5 Aurobindo Pharma Limited Recent Development
11.13 Unimark Remedies
11.13.1 Unimark Remedies Company Details
11.13.2 Unimark Remedies Business Overview
11.13.3 Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Introduction
11.13.4 Unimark Remedies Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.13.5 Unimark Remedies Recent Development
11.14 Savior Lifetec
11.14.1 Savior Lifetec Company Details
11.14.2 Savior Lifetec Business Overview
11.14.3 Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Introduction
11.14.4 Savior Lifetec Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
11.14.5 Savior Lifetec Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Antibiotics Active Pharmaceutical Ingredient Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Penicillin Antibiotics
Table 3. Key Players of Cephalosporins
Table 4. Key Players of Carbapenem Antibiotics
Table 5. Global Antibiotics Active Pharmaceutical Ingredient Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Antibiotics Active Pharmaceutical Ingredient Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Antibiotics Active Pharmaceutical Ingredient Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Regions (2016-2021)
Table 9. Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Regions (2022-2027)
Table 11. Antibiotics Active Pharmaceutical Ingredient Market Trends
Table 12. Antibiotics Active Pharmaceutical Ingredient Market Drivers
Table 13. Antibiotics Active Pharmaceutical Ingredient Market Challenges
Table 14. Antibiotics Active Pharmaceutical Ingredient Market Restraints
Table 15. Global Antibiotics Active Pharmaceutical Ingredient Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Players (2016-2021)
Table 17. Global Top Antibiotics Active Pharmaceutical Ingredient Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotics Active Pharmaceutical Ingredient as of 2020)
Table 18. Ranking of Global Top Antibiotics Active Pharmaceutical Ingredient Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Antibiotics Active Pharmaceutical Ingredient Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Antibiotics Active Pharmaceutical Ingredient Product Solution and Service
Table 22. Date of Enter into Antibiotics Active Pharmaceutical Ingredient Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2021)
Table 26. Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Antibiotics Active Pharmaceutical Ingredient Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Application (2016-2021)
Table 30. Global Antibiotics Active Pharmaceutical Ingredient Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size by Country (2022-2027) & (US$ Million)
Table 62. Sandoz International Company Details
Table 63. Sandoz International Business Overview
Table 64. Sandoz International Antibiotics Active Pharmaceutical Ingredient Product
Table 65. Sandoz International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 66. Sandoz International Recent Development
Table 67. Centrient Pharmaceuticals Company Details
Table 68. Centrient Pharmaceuticals Business Overview
Table 69. Centrient Pharmaceuticals Antibiotics Active Pharmaceutical Ingredient Product
Table 70. Centrient Pharmaceuticals Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 71. Centrient Pharmaceuticals Recent Development
Table 72. CordenPharma International Company Details
Table 73. CordenPharma International Business Overview
Table 74. CordenPharma International Antibiotics Active Pharmaceutical Ingredient Product
Table 75. CordenPharma International Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 76. CordenPharma International Recent Development
Table 77. ACS DOBFAR Company Details
Table 78. ACS DOBFAR Business Overview
Table 79. ACS DOBFAR Antibiotics Active Pharmaceutical Ingredient Product
Table 80. ACS DOBFAR Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 81. ACS DOBFAR Recent Development
Table 82. Nanjing Dorra Pharmaceutical Technology Company Details
Table 83. Nanjing Dorra Pharmaceutical Technology Business Overview
Table 84. Nanjing Dorra Pharmaceutical Technology Antibiotics Active Pharmaceutical Ingredient Product
Table 85. Nanjing Dorra Pharmaceutical Technology Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 86. Nanjing Dorra Pharmaceutical Technology Recent Development
Table 87. DAEWOONG PHARMACEUTICAL Company Details
Table 88. DAEWOONG PHARMACEUTICAL Business Overview
Table 89. DAEWOONG PHARMACEUTICAL Antibiotics Active Pharmaceutical Ingredient Product
Table 90. DAEWOONG PHARMACEUTICAL Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 91. DAEWOONG PHARMACEUTICAL Recent Development
Table 92. Parabolic Drugs Company Details
Table 93. Parabolic Drugs Business Overview
Table 94. Parabolic Drugs Antibiotics Active Pharmaceutical Ingredient Product
Table 95. Parabolic Drugs Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 96. Parabolic Drugs Recent Development
Table 97. Penam Laboratories Company Details
Table 98. Penam Laboratories Business Overview
Table 99. Penam Laboratories Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 100. Penam Laboratories Recent Development
Table 101. ASIATIC DRUGS & PHARMACEUTICALS Company Details
Table 102. ASIATIC DRUGS & PHARMACEUTICALS Business Overview
Table 103. ASIATIC DRUGS & PHARMACEUTICALS Antibiotics Active Pharmaceutical Ingredient Product
Table 104. ASIATIC DRUGS & PHARMACEUTICALS Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 105. ASIATIC DRUGS & PHARMACEUTICALS Recent Development
Table 106. Fresenius Kabi Company Details
Table 107. Fresenius Kabi Business Overview
Table 108. Fresenius Kabi Antibiotics Active Pharmaceutical Ingredient Product
Table 109. Fresenius Kabi Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 110. Fresenius Kabi Recent Development
Table 111. The United Laboratories International Holdings Company Details
Table 112. The United Laboratories International Holdings Business Overview
Table 113. The United Laboratories International Holdings Antibiotics Active Pharmaceutical Ingredient Product
Table 114. The United Laboratories International Holdings Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 115. The United Laboratories International Holdings Recent Development
Table 116. Aurobindo Pharma Limited Company Details
Table 117. Aurobindo Pharma Limited Business Overview
Table 118. Aurobindo Pharma Limited Antibiotics Active Pharmaceutical Ingredient Product
Table 119. Aurobindo Pharma Limited Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 120. Aurobindo Pharma Limited Recent Development
Table 121. Unimark Remedies Company Details
Table 122. Unimark Remedies Business Overview
Table 123. Unimark Remedies Antibiotics Active Pharmaceutical Ingredient Product
Table 124. Unimark Remedies Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 125. Unimark Remedies Recent Development
Table 126. Savior Lifetec Company Details
Table 127. Savior Lifetec Business Overview
Table 128. Savior Lifetec Antibiotics Active Pharmaceutical Ingredient Product
Table 129. Savior Lifetec Revenue in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021) & (US$ Million)
Table 130. Savior Lifetec Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Type: 2020 VS 2027
Figure 2. Penicillin Antibiotics Features
Figure 3. Cephalosporins Features
Figure 4. Carbapenem Antibiotics Features
Figure 5. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Application: 2020 VS 2027
Figure 6. Pharmaceutical Companies Case Studies
Figure 7. Contract Manufacturing Organizations (CMOs) Case Studies
Figure 8. Contract Development & Manufacturing Organizations (CDMOs) Case Studies
Figure 9. Antibiotics Active Pharmaceutical Ingredient Report Years Considered
Figure 10. Global Antibiotics Active Pharmaceutical Ingredient Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Antibiotics Active Pharmaceutical Ingredient Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Regions: 2020 VS 2027
Figure 13. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Regions (2022-2027)
Figure 14. Global Antibiotics Active Pharmaceutical Ingredient Market Share by Players in 2020
Figure 15. Global Top Antibiotics Active Pharmaceutical Ingredient Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Antibiotics Active Pharmaceutical Ingredient as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Antibiotics Active Pharmaceutical Ingredient Revenue in 2020
Figure 17. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Type (2016-2021)
Figure 18. Global Antibiotics Active Pharmaceutical Ingredient Revenue Market Share by Type (2022-2027)
Figure 19. North America Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027)
Figure 21. North America Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027)
Figure 22. North America Antibiotics Active Pharmaceutical Ingredient Market Share by Country (2016-2027)
Figure 23. United States Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027)
Figure 27. Europe Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027)
Figure 28. Europe Antibiotics Active Pharmaceutical Ingredient Market Share by Country (2016-2027)
Figure 29. Germany Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Antibiotics Active Pharmaceutical Ingredient Market Share by Region (2016-2027)
Figure 39. China Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027)
Figure 47. Latin America Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027)
Figure 48. Latin America Antibiotics Active Pharmaceutical Ingredient Market Share by Country (2016-2027)
Figure 49. Mexico Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Antibiotics Active Pharmaceutical Ingredient Market Share by Country (2016-2027)
Figure 55. Turkey Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Antibiotics Active Pharmaceutical Ingredient Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Sandoz International Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 59. Centrient Pharmaceuticals Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 60. CordenPharma International Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 61. ACS DOBFAR Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 62. Nanjing Dorra Pharmaceutical Technology Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 63. DAEWOONG PHARMACEUTICAL Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 64. Parabolic Drugs Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 65. Penam Laboratories Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 66. ASIATIC DRUGS & PHARMACEUTICALS Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 67. Fresenius Kabi Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 68. The United Laboratories International Holdings Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 69. Aurobindo Pharma Limited Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 70. Unimark Remedies Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 71. Savior Lifetec Revenue Growth Rate in Antibiotics Active Pharmaceutical Ingredient Business (2016-2021)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

以下、関連資料のご紹介

世界の静菌性抗生物質市場規模・現状・予測（2021年-2027年）

Global Bacteriostatic Antibiotics Market Size, Status and Forecast 2021-2027
QFJ1-5609 2021年6月 105Pages
QYResearch社発行の本調査レポートでは、静菌性抗生物質の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（テトラサイクリン、ドキシサイクリン、クロラムフェニコール、エリスロマイシン、フシド酸、スルホンアミド、トリメトプリム、マクロライド、リンコ...

世界の全身性抗生物質市場規模・現状・予測（2021年-2027年）

Global Systemic Antibiotics Market Size, Status and Forecast 2021-2027
QFJ1-4928 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、全身性抗生物質の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（βラクタム・βラクタマーゼ阻害剤、キノロン、マクロライド、その他）、用途別市場規模（病院、専門クリニック、在宅医療、その他）、主要地域別市...

インスリン有効成分のグローバル市場調査 2019年

Global Insulin Active Pharmaceutical Ingredient Market Professional Survey Report 2019
QYR9NV06910 2019年11月12日 105Pages
※本調査レポートは、インスリン有効成分の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、化学合成、動物エキスに、用途別には、動物インスリン、一般ヒトインスリン、...

世界のアクティブアンテナユニット（AAU）市場規模・現状・予測（2021年-2027年）

Global Active Antenna Unit (AAU) Market Size, Status and Forecast 2021-2027
QFJ1-3018 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、アクティブアンテナユニット（AAU）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（RRU＆アンテナ疎結合AAU、低消費電力＆ディープカバレッジAAU、マッシブMiMo AAU、その他）、用途別市場...

世界の自動車用アクティブコーナリングシステム市場規模・現状・予測（2021年-2027年）

Global Automotive Active Cornering System Market Size, Status and Forecast 2021-2027
QFJ1-2083 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、自動車用アクティブコーナリングシステムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（石油自動車、ハイブリッド車、電気自動車、その他）、用途別市場規模（SUV、その他）、主要地域別市場規模（北米、アメ...

世界の潜水艦アクティブパルス分析システム市場規模・現状・予測（2021年-2027年）

Global Submarine Active Pulse Analysis System Market Size, Status and Forecast 2021-2027
QFJ1-3679 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、潜水艦アクティブパルス分析システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（パッシブソナーシステムタイプ、アクティブソナーシステムタイプ）、用途別市場規模（原子力潜水艦、ディーゼル電気潜水艦、非...

世界のヒドロキシカンプトテシン(HCPT)市場規模・現状・予測（2021年-2027年）

Global Hydroxy Camptothecine (HCPT) Market Size, Status and Forecast 2021-2027
QFJ1-4336 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、ヒドロキシカンプトテシン(HCPT)の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（注射、錠剤、カプセル）、用途別市場規模（原発性肝細胞がん、胃がん、頭頸部がん、膀胱がん、大腸がん、肺がん、白血病）、...

世界の潜水艦アクティブインターセプト＆測距システム市場規模・現状・予測（2021年-2027年）

Global Submarine Active Intercept and Ranging System Market Size, Status and Forecast 2021-2027
QFJ1-3678 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、潜水艦アクティブインターセプト＆測距システムの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（パッシブレンジ＆インターセプトソナータイプ、アクティブレンジ＆インターセプトソナータイプ）、用途別市場規模（...

世界の扁桃周囲膿瘍治療市場規模・現状・予測（2021年-2027年）

Global Peritonsillar Abscess Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5940 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、扁桃周囲膿瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、ステロイド薬、鎮痛薬、経口吸引システム、往復手術装置、扁桃摘出装置）、用途別市場規模（病院、外来手術センター、専門クリニック、...

世界のカメラライダーシステム用アクティブアライメント市場規模・現状・予測（2021年-2027年）

Global Active Alignment of Cameras Lidar System Market Size, Status and Forecast 2021-2027
QFJ1-2671 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、カメラライダーシステム用アクティブアライメントの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（機器、ソフトウェア）、用途別市場規模（民間用、軍用）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日...

世界の静菌性抗生物質市場規模・現状・予測（2021年-2027年） Bacteriostatic antibiotics limit the growth of bacteria by interfering with bacterial protein production, DNA replication, or other aspects of bacterial cellular metabolism. Market Analysis and Insights: Global Bacteriostatic Antibiotics Market The global Bacteriostatic Antibiotics market size is pr…
世界の全身性抗生物質市場規模・現状・予測（2021年-2027年） It refers to a class of secondary metabolites produced by microorganisms (including bacteria, fungi, actinomycetes) or higher animals and plants that have anti-pathogens or other activities during their life, and can interfere with the development of other living cells. substance. Market Analysis an…
インスリン有効成分のグローバル市場調査 2019年 The global Insulin Active Pharmaceutical Ingredient market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Insulin Active Pharmaceutical Ingredient volume and value at global level, regional level and comp…
アミノグリコシド系抗生物質のグローバル市場2021 Aminoglycosides are a class of antibiotics used mainly in the treatment of aerobic gram-negative bacilli infections, although they are also effective against other bacteria including Staphylococci and Mycobacterium tuberculosis. They are often used in combination with other antibiotics. The classifi…
世界の医薬品受託研究・製造（CRAM）市場規模・現状・予測（2021年-2027年） The field of contract research and manufacturing broadly encompasses those services in the pharmaceutical and biotechnology sectors that require extensive research and development and large-scale manufacturing facilities. The drug development processes in emerging economies are witnessing significan…